C9orf72 and frontotemporal dementia: Computational neuroimaging techniques have consistently captured hippocampal GM changes which was initially thought to be more significant in ALS patients carrying the C9orf72 hexanucleotide repeats (40), but later studies showed similarly extensive hippocampal degeneration in C9orf72 negative ALS-FTD patients (78).